Evolution of 352 Adult Patients Treated with Androgens: Short and Long-term Results of a Prospective Study

  • C. Dresch
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 24)


The short and long-term evolution of aplastic anemias and the choice of their treatment remain a matter of discussion. Since the techniques of homologous bone marrow transplants have made it possible to offer a new, but hazardous therapy to some patients, with low chances of survival, the need of accurate factors of prognosis, and a better knowledge of the short- and long-term prognosis of androgen-treated cases, are particularly necessary.


Aplastic Anemia Reticulocyte Count Anabolic Androgenic Steroid Prognosis Factor Severe Aplastic Anemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alexanian, R., Nadell, J., Alfrey, C.: Oxymetholone treatment for the anemia of bone marrow failure. Blood 40, 353 (1972)PubMedGoogle Scholar
  2. 2.
    Camitta, B. M., Thomas, E. D., Nathan, D. G., Santos, G., Gordon-Smith, E. C., Gale, R. P., Rappeport, S. M. and Storb, R.: Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48, 63 (1976)PubMedGoogle Scholar
  3. 3.
    Corneo, G., Cartellaro, M. and Maiolo, A. T.: Some clinical and laboratory aspects and an evaluation of the androgen-glucocorticoid treatment. Acta Haemat. 46, 50–59 (1971)PubMedCrossRefGoogle Scholar
  4. 4.
    Daiber, A., Herve, L., Coni, I. and Donosco, A.: Treatment of aplastic anemia with nandolone decancate. Blood 36, 748–753 (1971)Google Scholar
  5. 5.
    Davis, S. and Rubin, A. D.: Treatment and prognosis in aplastic anemia. Lancet 1, 871–873 (1972)PubMedCrossRefGoogle Scholar
  6. 6.
    Duarte, L., Lopez Sandoual, R., Esquivel, F. and Sanchez Medal, L.: Androstane therapy on aplastic anemia. Acta Haemat. 47, 140–145 (1972)PubMedCrossRefGoogle Scholar
  7. 7.
    Frich, B., Lewis, S. M.: The bone marrow in aplastic anemia. Diagnostic and prognostic feature. J. Clin. Pathol. 27, 231 (1974)CrossRefGoogle Scholar
  8. 8.
    Heimpel, H., Reebock, C., Van Eimeren, W.: Verlauf und Prognose der Panmyelopathie und der isolierten aplastischen Anämie. Eine retrospektive Studie zu 78 Patienten. Blut 30, 235 (1975)PubMedCrossRefGoogle Scholar
  9. 9.
    Hellriegel, K. P., Zuger, M., Gross, R.: Prognosis in acquired aplastic anaemia-An approach in the selection of patients for allogenesic bone marrow transplantation. Lancet II, 647 (1976)Google Scholar
  10. 10.
    Hirota, Y. and Hibino, S.: Effect of Androstanes on Aplastic Anemia in Japanese. In: Aplastic Anemia. Japan Med. Res. Found (ed.). Tokyo 1978, 377–383Google Scholar
  11. 11.
    Hast, R., Skarberg, K. O., Engstedt, L., Jameson, S., Killander, A., Lundh, B., Reizenstein, P., Uden, A. M. and Wadman, B.: Oxymetholone treatment in agenerative anemia. II: Remission and survival — a prospective study. Scand. J. Haematol. 16, 90–100 (1976)PubMedCrossRefGoogle Scholar
  12. 12.
    Lewis, S. M.: Course and prognosis in aplastic anaemia. Brit. Med. J. 1, 1027 (1965)PubMedCrossRefGoogle Scholar
  13. 13.
    Lohrmann, H. P., Kern, P., Niethammer, D., Heimpel, H.: Identification of high risk patients with aplastic anemia in selection for allogeneic bone marrow transplantation. Lancet 11, 647 (1976)CrossRefGoogle Scholar
  14. 14.
    Lepson, J. H., Gardner, F. H., Gorshein, D., Hait, W. M.: Current concepts of the action of androgenic steroids on zrythropoiese. J. Pediatrics 83, 703 (1973)CrossRefGoogle Scholar
  15. 15.
    Lynch, R. E., Williams, D. M., Reading, J. C., Cartwright, G. E.: The prognosis in aplastic anemia. Blood 45, 517–528 (1975)PubMedGoogle Scholar
  16. 16.
    Mac Neil, B. J., Rappeport, J. M., Nathan, D. G.: Indium chloride scintigraphy: an index of severity in patients with aplastic anaemia. Brit. J. Haematol. 34, 599 (1976)CrossRefGoogle Scholar
  17. 17.
    Najean, Y., Bernard, J., Wainberger, M., Dresch, C., Boiron, M., Seligmann, M.: Evolution et pronostic des pancytopénies idiopathiques. Etudes de 116 observations. Nouv. Rev. Fr. Hémat. 5, 635 (1965)Google Scholar
  18. 18.
    Najean, Y., Pecking, A.: The prognosis factors in acquired aplastic anemia- A study of 352 cases. To be publishedGoogle Scholar
  19. 19.
    Najean, Y., Laprevotte, Y., Schaison, G., Dresch, C. et Ardaillou, N.: Evolution tardive des pancytopénies chroniques traitées avec succès par les androgenes. Nouv. Rev. Fr. Hémat. 9, 23–32 (1969)Google Scholar
  20. 20.
    Perugini, S., Lusvarghi, E. and Vaccari, G.: Androgenes et corticosteroides associés dans le traitement des aplasies medullaires acquises. Schweiz Med. Wschr. 100, 1982–1984 (1970)PubMedGoogle Scholar
  21. 21.
    Sanchez-Medal, L., Gomez-Leal, A., Duarte, L. and Rico, M.: Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood 34, 283–300 (1969)PubMedGoogle Scholar
  22. 22.
    Scott, J. L., Cartwright, G. E., Wintrobe, M. M.: Acquired aplastic anemia: an analysis of 39 cases and review of the pertinent literature. Medicine 38, 119–172 (1959)PubMedGoogle Scholar
  23. 23.
    Shahidi, N. T. and Diamond, L. K.: Testosterone-induced remission in aplastic anemia of both acquired and congenital type: further observations in 24 cases. New Engl. J. Med. 264, 953–967 (1961)PubMedCrossRefGoogle Scholar
  24. 24.
    Shinohara, K., Matsumoto, N., Tajiri, M., Nakashima, K., Ariyoshi, K., Miwa, S. and Miyaji: Oxymetholone treatment in aplastic anemia. Acta Haemat. Jap. 37, 255–265 (1974)PubMedGoogle Scholar
  25. 25.
    Singer, J. W. and Adamson, J. W.: Steroids and hematopoiesis. III: The response of granulocytic and erythroid colony-forming cells to steroid of different classes. Blood 48, 855–854 (1976)PubMedGoogle Scholar
  26. 26.
    Thong, K. L., Mant, M. J. and Grace, M. G.: Lack of effect of prednisone administration on bleeding time and platelet function of normal subjects. Brit. J. Haemat. 38, 373–380 (1978)PubMedCrossRefGoogle Scholar
  27. 27.
    Van Der Weyden, M. and Firkin, B. G.: The management of aplastic anaemia in adults. Brit. J. Haemat. 22, 1–7 (1972)PubMedCrossRefGoogle Scholar
  28. 28.
    Velde, J. T., Haak, H. L.: Aplastic anaemia. Histological investigation (methacrylate embidded bone marrow biopsy specimens: correlation with survival after conventional treatment in 15 adult patients). Brit. J. Haemat. 35, 61 (1977)CrossRefGoogle Scholar
  29. 29.
    Whang, K. S.: Aplastic Anemia in Korea. A Clinical Study of 309 Cases. In: Aplastic Anemia. Japan Med. Res. Found. (ed.). Tokyo, 1978, 225–240Google Scholar
  30. 30.
    Williams, D. M., Lynch, R. C., Cartwright, G. E.: Drug induced aplastic anemia. Seminars Hemat. 10, 195–223 (1977)Google Scholar
  31. 31.
    Yamagishi, M., Kariyone, S. and Wakisaka, G.: Hematological effect of corticosteroids and anabolic steroids on aplastic anemia patients. Acta Hemat. Jap. 36, 9–24 (1973)Google Scholar
  32. 32.
    Zittoun, R., Bernadou, A., Blanc, C. M., Bilski-Pasquier, G. et Bousser, J.: La metenolone dans le traitement des aplasies médullaires. Presse Méd. 76, 445–449 (1968)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • C. Dresch

There are no affiliations available

Personalised recommendations